𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Review article: the role of non-biological drugs in refractory inflammatory bowel disease

✍ Scribed by S. C. Ng; F. K. L. Chan; J. J. Y. Sung

Book ID
108606163
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
207 KB
Volume
33
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Drug development in inflammatory bowel d
Drug development in inflammatory bowel disease: The role of the FDA
✍ Conor Lahiff; Sunanda Kane; Alan C. Moss πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 198 KB πŸ‘ 2 views

All medicinal compounds sold in the United States for inflammatory bowel disease (IBD) are regulated by the Food and Drug Administration (FDA) via a number of regulations dating back to 1906. The primary contemporary role of the FDA is in the assessment of safety and efficacy, and subsequent marketi